LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,416,041
تعداد دریافت فایل اصل مقاله11,291,713
Liang, Yan-Lian, Shi, Yu, Su, Yu-Qing, Wu, Fan, Liang, Yanwen, Fan, Xiuchu, Lin, Jiansuo, Liu, Yi, Peng, Long, Ren, Jianwei, Liang, Shuang. (1401). Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus. سامانه مدیریت نشریات علمی, 20(1), 129-134. doi: 10.22034/iji.2023.93993.2273
Yan-Lian Liang; Yu Shi; Yu-Qing Su; Fan Wu; Yanwen Liang; Xiuchu Fan; Jiansuo Lin; Yi Liu; Long Peng; Jianwei Ren; Shuang Liang. "Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus". سامانه مدیریت نشریات علمی, 20, 1, 1401, 129-134. doi: 10.22034/iji.2023.93993.2273
Liang, Yan-Lian, Shi, Yu, Su, Yu-Qing, Wu, Fan, Liang, Yanwen, Fan, Xiuchu, Lin, Jiansuo, Liu, Yi, Peng, Long, Ren, Jianwei, Liang, Shuang. (1401). 'Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus', سامانه مدیریت نشریات علمی, 20(1), pp. 129-134. doi: 10.22034/iji.2023.93993.2273
Liang, Yan-Lian, Shi, Yu, Su, Yu-Qing, Wu, Fan, Liang, Yanwen, Fan, Xiuchu, Lin, Jiansuo, Liu, Yi, Peng, Long, Ren, Jianwei, Liang, Shuang. Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus. سامانه مدیریت نشریات علمی, 1401; 20(1): 129-134. doi: 10.22034/iji.2023.93993.2273

Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus

Iranian Journal of Immunology
دوره 20، شماره 1، خرداد 2023، صفحه 129-134    اصل مقاله (586.71 K)
نوع مقاله: Case Report
شناسه دیجیتال (DOI): 10.22034/iji.2023.93993.2273
نویسندگان
Yan-Lian Liang1؛ Yu Shi2؛ Yu-Qing Su1؛ Fan Wu1؛ Yanwen Liang3؛ Xiuchu Fan3؛ Jiansuo Lin3؛ Yi Liu4؛ Long Peng1؛ Jianwei Ren5؛ Shuang Liang* 1
1Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China.
2Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.
3R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, Guangdong, P.R.China.
4Guangdong Key Laboratory for Research and Development of Natural Drugs, Department of Pharmacology, Marine Medicine Research Institute, Guangdong Medical University, Zhanjiang, Guangdong, P.R.China.
5Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China. R&D Division, Shenzhen Ritzcon Biological Technology Co., Ltd., Shenzhen, Guangdong, P.R.China. Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong SAR, P.R.China.
چکیده
Several cases of the hemolytic disease of the fetus and newborn (HDFN) caused by immunoglobulin G (IgG) anti-M antibodies have been reported, in which almost all the HDFN-associated anti-M were warmly reacting. Here we report two cases of severe HDFN associated with cold-reacting IgG anti-M. In both cases, pregnancy was terminated, in weeks 33 and 23 respectively, due to a diagnosis of fetal growth retardation (FGR). To our knowledge, these are the most severe HDFN cases caused by cold-reacting IgG anti-M.
کلیدواژه‌ها
Anti-M Antibody؛ Cold-reacting IgG؛ HDFN؛ MNS Blood Group
مراجع
  1. Levine P, Pollack W. Hemolytic disease of the fetus and newborn. Med Clin North Am. 1965; 49:1647-60.
  2. de Haas M, Thurik FF, Koelewijn JM, et al. Haemolytic disease of the fetus and newborn. Vox Sang. 2015; 109(2):99-113.
  3. Egbor M, Knott P, Bhide A. Red-cell and platelet alloimmunisation in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012; 26(1):119-32.
  4. 4. Abbasi N, Johnson J, Ryan G. Fetal anemia. Ultrasound Obstet Gynecol. 2017; 50:145-53.
  5. 5. Prefumo F, Fichera A, Fratelli N, Sartori E. Fetal anemia: Diagnosis and management. Best Pract Res Clin Obstetr Gynaecol. 2019; 58:2-14.
  6. 6. Ghesquière L, Garabedian C, Coulon C, Verpillat P, Rakza T, Wibaut B, et al. Management of red blood cell alloimmunization in pregnancy. J Gynecol Obstetr Hum Reprod. 2018; 47:197-204.
  7. 7. Yasuda H, Ohto H, Nollet KE, Kawabata K, Saito S, Yagi Y, et al. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature. Transfus Med Rev. 2014; 28:1-6.
  8. Armstrong B, Smart E. Haemolytic diseases. ISBT Science Series 2008;3:93-109.
  9. 9. Heathcote DJ, Carroll TE, Flower RL. Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned? Transfus Med Rev. 2011; 25:111-24.
  10. Habibi B, Bretagne M, Bretagne Y, et al. Blood group antigens on fetal red cells obtained by umbilical vein puncture under ultrasound guidance: a rapid hemagglutination test to check for contamination with maternal blood. Pediatr Res. 1986; 20(11):1082-4.
  11. Xu P, Li Y, Yu H. Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients. Blood Transfus. 2014; 12(1):56-60.
  12. 12. Makroo RN, Arora B, Bhatia A, Chowdhry M, Luka RN. Clinical significance of antibody specificities to M, N and Lewis blood group system. Asian J Transfus Sci. 2014; 8:96.
  13. 13. Wikman A, Edner A, Gryfelt G, Jonsson B, Henter JI. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization. Transfusion. 2007; 47:911-7.
  14. 14. Ishida A, Ohto H, Yasuda H, Negishi Y, Tsuiki H, Arakawa T, et al. Anti-M antibody induced prolonged anemia following hemolytic disease of the newborn due to erythropoietic suppression in 2 siblings. J Pediatr Hematol Oncol. 2015; 37:e375-e7.
  15. 15. Stetson B, Scrape S, Markham KB. Anti-M alloimmunization: management and outcome at a single institution. Am J Perinatol Rep. 2017; 7:e205-e10.
  16. 16. Philip J, Kushwaha N, Jain N. Report of two cases of anti-M antibody in antenatal patients. Asian J Transfus Sci. 2015; 9:89.
  17. 17. Parsh BS. Hemolytic disease of the newborn due to anti S antibodies. J Natl Med Assoc. 2000; 92:91.
 

  1. Li S, He Z, Luo Y, et al. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management. BMC Pregnancy Childbirth. 2020; 20(1):539.
  2. Yudin J, Heddle NM. A 13-question approach to resolving serological discrepancies in the transfusion medicine laboratory. Lab Med. 2014;45(3):193-206.
  3. Smith ML, Beck ML. The immunoglobulin structure of human anti-M agglutinins. Transfusion. 1979; 19(4):472-4.
  4. Duro EA, Desalvo L, Kuret S. Severe hemolytic disease of the newborn caused by anti-m antibodies. Iranian J Pediatr. 2013; 23:607-8.
  5. Mohd Nazri H, Noor Haslina MN, Shafini MY, et al. Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss. Malays J Pathol. 2017; 39(1):73-6.
  6. 23. Andersen LH, Jacob EK, McThenia SS, Tauscher CD, Patterson ER, Oliveira JL, et al. Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti‐M reacting optimally at cold temperatures. Transfusion. 2021; 61:974-8.
  7. Crispin P, Sliwinski K, Wilson C, et al. Cold reacting anti-M causing delayed hemolytic disease of the newborn. Transfusion. 2019; 59(12):3575-9.
  8. Gao XY, Huang H, Li LD. Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases. Zhonghua Er Ke Za Zhi. 2009; 47(9):648-52.
  9. Bajic G, Degn SE, Thiel S, et al. Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J. 2015; 34(22):2735-57.
آمار
تعداد مشاهده مقاله: 848
تعداد دریافت فایل اصل مقاله: 568


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب